Morphological and immunohistochemical study of ovarian and tubal dysplasia associated with tamoxifen

Submitted: 29 July 2013
Accepted: 3 March 2014
Published: 15 April 2014
Abstract Views: 1707
PDF: 680
HTML: 468
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Ovarian epithelial dysplasia was initially described in material from prophylactic oophorectomies for BReast CAncer gene (BRCA) mutation. Similar histopathological abnormalities have been revealed after ovulation stimulation. Given that tamoxifen (TAM) has a clomid-like effect and is sometimes used to induce ovulation, we studied the morphological features and immunohistochemical expression patterns of neoplasia-associated markers in adnexectomies previously exposed to TAM for breast cancer. We blindly reviewed 173 histopathological slides of adnexectomies according to three groups – oophorectomie sassociated with TAM exposure (n=42), oophorectomies associated with clomiphene exposure (n=15) and a spontaneously fertile non cancerous control group (n=116). Morphological features (with an ovarian and tubal dysplasia scoring system) and immunohistochemical expression patterns of Ki-67, p53 and Aldehyde dehydrogenase 1 (ALDH1 is an enzyme significantly associated with earlystage ovarian cancer) were evaluated and correlated. Mean tubal dysplasia score was significantly higher in the TAM group and clomiphene group than in controls (respectively 7.8 vs 3.5, P<0.007 and 6.8 vs 3.5, P=0.008). There is no statistical difference for the ovarian score in TAM group in comparison with the control group whereas we found a significant score for clomiphen group (6.5, P=0.009). Increased ALDH1 expression was observed in the two exposed group whereas expression patterns of Ki67 and p53 were moderate. Interestingly, ALDH1 expression was low in non-dysplastic epithelium, high in dysplasia, and constantly low in the two carcinoma. Furthermore, we confirm our previous results showing that ALDH1 may be a useful tissue biomarker in the subtle histopathological diagnosis of tubo-ovarian dysplasia.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Supporting Agencies

La ligue contre le cancer Foundation
G. Chene, Centre Jean Perrin, ERTICA Research Team
Department of Histopathology
N. Radosevic-Robin, Centre Jean Perrin, ERTICA Research Team
Department of Histopathology
A.S. Tardieu, Centre Jean Perrin, ERTICA Research Team
Department of Histopathology
A. Cayre, Centre Jean Perrin, ERTICA Research Team
Department of Histopathology
I. Raoelfils, Centre Jean Perrin, ERTICA Research Team
Department of Histopathology
P. Dechelotte, CHU Estaing, Clermont-Ferrand
Department of Histopathology
J. Dauplat, Centre Jean Perrin
Department of Surgery
F. Penault Llorca, Centre Jean Perrin
Department of Surgery

How to Cite

Chene, G., Radosevic-Robin, N., Tardieu, A., Cayre, A., Raoelfils, I., Dechelotte, P., … Penault Llorca, F. (2014). Morphological and immunohistochemical study of ovarian and tubal dysplasia associated with tamoxifen. European Journal of Histochemistry, 58(2). https://doi.org/10.4081/ejh.2014.2251

Similar Articles

<< < 1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.

Publication Facts

Metric
This article
Other articles
Peer reviewers 
1
2.4

Reviewer profiles  N/A

Author statements

Author statements
This article
Other articles
Data availability 
N/A
16%
External funding 
N/A
32%
Competing interests 
N/A
11%
Metric
This journal
Other journals
Articles accepted 
57%
33%
Days to publication 
259
145

Indexed in

Editor & editorial board
profiles
Academic society 
N/A